Research Institute

Hyo-Jong Research Institute

Hyo : 曉 (Dawn), Jong : 鐘 (Bell)

Opening a new era by ringing the bell

종근당 연구소 사진

the realization of
a disease-free human society

Since the foundation, Chong Kun Dang has been pursuing a disease-free society
by developing excellent medicines.Cognizant of the importance of drug discovery, Chong Kun Dang was the first in Korea to run its own research institute it also invested a huge portion of its resources in nurturing and training research manpower.
Chong Kun Dang Research Institute is characterized by three independent laboratories: The New Drug Discovery Labs, for identifying innovative drug candidates, The Technology Development Labs, dedicated to generic drugs,
APIs, and botanical drugs, and the Bio Research Labs for developing antibodies, vaccines, and recombinant proteins. 
Chong Kun Dang was able to stand as one of the top local pharmaceutical companies with distinguished achievements in drug development including the following.

R&D Vision & Strategy

“Better Life through Better Medicine”
  • Platform

  • Focus on medical
    unmet needs

  • Globalization

  • New Drug

    Raising competitiveness in the
    global market

    • - Open Innovation
    • - New drug discovery through platform
        target HDAC6
        (Immunology, Neurology, Oncology)
  • Bio research center

    Securing new growth engine

    • - Infrastructure of Bio GMP manufacturing
    • - Export of biosimilars to global market
    • - Development of new biological drugs
  • Technology development

    Creating sustainable growth engine

    • - Expansion of IMD pipeline
    • - Overseas expansion through platform
        technology utilization of Liquistal®

R&D Expenditure